Quetiapine Fumarate 200 mg/1 (Quetiapine Fumarate TABLET, EXTENDED RELEASE) 200 mg/1

Quetiapine Fumarate 200 mg Extended Release Tablets are a prescription medication used to manage certain mental health conditions. This extended-release formulation is designed for oral administration and is manufactured by Novast Laboratories, Ltd.

Strength

200 mg/1

Pack Size

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-637-60)

Manufacturer / TM Owner

Novast Laboratories, Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quetiapine Fumarate 200 mg Extended Release Tablets are commonly used to treat symptoms associated with schizophrenia and bipolar disorder. This medication may also be prescribed for other mental health conditions as determined by a healthcare provider. Quetiapine is often used to help manage mood swings, hallucinations, and other symptoms related to these conditions.

Side Effects

Quetiapine Fumarate 200 mg Extended Release Tablets may cause drowsiness, dizziness, and dry mouth. Some users may experience weight gain, constipation, or blurred vision. It is important to discuss any side effects with a healthcare provider to ensure safe and effective use.

Precautions & Warnings

Quetiapine Fumarate 200 mg Extended Release Tablets should be taken exactly as prescribed. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Patients with a history of heart disease, seizures, or low white blood cell counts should consult their healthcare provider before starting this medication.

Avoid Interactions

Quetiapine Fumarate 200 mg Extended Release Tablets may interact with other medications, including antidepressants, antihistamines, and certain pain relievers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Quetiapine Fumarate is used to treat symptoms associated with schizophrenia and bipolar disorder, as well as other mental health conditions.

Quetiapine Fumarate 200 mg Extended Release Tablets should be taken orally, exactly as prescribed by your healthcare provider.

Common side effects include drowsiness, dizziness, dry mouth, weight gain, constipation, and blurred vision.

It is recommended to avoid alcohol while taking Quetiapine Fumarate, as it can increase the risk of side effects.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.